Author Archive: Suraj Madoori
TAG Report Challenges Public Health to “Finish the Job” on the AIDS Epidemic
In 2015, the NHAS in its current form is set to expire. As we reflect, questions come to mind: what have we achieved? was it successful? what could we do better? In 18-pages, the Treatment Action Group (TAG) and a working-group attempt to start answering these questions for revisioning a 2015 NHAS. In doing so, [...]
Tax Week: Take Action with the Robin Hood Tax!
With Tax Week (April 15) on the horizon, supporters and proponents of the Robin Hood Tax are preparing for a Tax Week like no other: On April 15: Let’s demand a Robin Hood Tax to create jobs, provide health care and education, ends AIDS and fight climate change at home and around the world. On [...]
PWN-USA Announces its Inaugural Board of Directors & Elected Officers
The following announcement has been posted on the behalf of our network partners, the Positive Women’s Network – USA: For Immediate Release Contact: Naina Khanna, Executive Director, naina.khanna.work@gmail.com Sonia Rastogi, Communications Director, sbrastogi@gmail.com Dear Community, Positive Women’s Network – USA (PWN-USA) congratulates our inaugural Board of Directors and elected Officers. PWN-USA’s Board members bring decades [...]
Jim Pickett: “VOICE results important to new prevention technology research”
By Jim Pickett, IRMA – The VOICE results are extremely important to the field of new prevention technology research. I hope current/future/much-needed discussions about VOICE don’t get drowned out by the HYPE (yes, all caps HYPE) surrounding the “baby cure” story which has dominated coverage out of CROI so far. If there is one VOICE [...]
Advocates Respond to the VOICE Trial Results Released at CROI
Following the release of the VOICE trial results at the Conference on Retroviruses & Opportunistic Infections (CROI) in Atlanta today, multiple organizations including AVAC and IRMA, responded with statements summarizing the results and impact. Organizations detail a key issue of low participant adherence to the regimen of daily oral tenofovir and tenofovir gel as a [...]
